Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

No single treatment is consistently effective for alopecia areata, and more research is needed.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

The model helps understand and improve treatments for alopecia areata by simulating hair growth and immune cell interactions.

People with alopecia areata are more likely to have other immune-related conditions.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.